Outpatient management for PE

In this large multi-center trial of patients with acute symptomatic PE (PE severity index class I or II), they were randomized to in or outpatient treatment with LMWH. There were no significant differences between the groups in 90 day recurrent VTE, death, or major bleeding. LOS was 0.5 days vs 3.9 days. Outpatient therapy is feasible, safe, and lower cost in low risk patients with PE (abstract)

This entry was posted in Hematology and Oncology. Bookmark the permalink.

Comments are closed.